Do analysts prefer SIGA or ARDX?

Ardelyx has a consensus price target of $13.90, suggesting a potential upside of 299.43%. Given Ardelyx's stronger consensus rating and higher possible upside, analysts plainly believe Ardelyx is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Siga Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ardelyx 2 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.75

Do analysts rate SIGA or IVA?

Inventiva has a consensus price target of $15.75, suggesting a potential upside of 356.52%. Given Inventiva's stronger consensus rating and higher possible upside, analysts plainly believe Inventiva is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Siga Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Inventiva 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 3 Strong Buy rating(s) 3.09

Which has preferable valuation & earnings, SIGA or IVA?

Siga Technologies has higher revenue and earnings than Inventiva. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Siga Technologies $53.66M 4.24 $23.28M -$0.05 N/A Inventiva $4.48M 159.85 -$400.67M N/A N/A

Do analysts rate ACHV or SIGA?

Achieve Life Sciences presently has a consensus price target of $15.00, suggesting a potential upside of 91.57%. Given Achieve Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe Achieve Life Sciences is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Achieve Life Sciences 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.00 Siga Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer GLAS or SIGA?

Glass House Brands presently has a consensus price target of $16.00, suggesting a potential upside of 104.66%. Given Glass House Brands' stronger consensus rating and higher probable upside, analysts clearly believe Glass House Brands is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Glass House Brands 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Siga Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, GLAS or SIGA?

Siga Technologies has higher revenue and earnings than Glass House Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Glass House Brands N/A N/A N/A N/A N/A Siga Technologies $53.66M 4.24 $23.28M -$0.05 N/A

Do analysts prefer SIGA or GYRE?

Gyre Therapeutics has a consensus price target of $16.00, suggesting a potential upside of 116.22%. Given Gyre Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Gyre Therapeutics is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Siga Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Gyre Therapeutics 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67

Siga Technologies (SIGA) Competitors

$3.17 -0.09 (-2.76%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$3.16 -0.01 (-0.19%)

As of 09/23/2026 07:30 PM Eastern

Compare

SIGA vs. ARDX, IVA, ACHV, GLAS, and GYRE

Should you buy Siga Technologies stock or one of its competitors? Siga Technologies's main competitors and comparable companies include Ardelyx (ARDX), Inventiva (IVA), Achieve Life Sciences (ACHV), Glass House Brands (GLAS), and Gyre Therapeutics (GYRE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Siga Technologies compare to Ardelyx?

Siga Technologies (NASDAQ:SIGA) and Ardelyx (NASDAQ:ARDX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

55.4% of Siga Technologies shares are held by institutional investors. Comparatively, 58.9% of Ardelyx shares are held by institutional investors. 2.7% of Siga Technologies shares are held by company insiders. Comparatively, 5.3% of Ardelyx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Siga Technologies has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market. Comparatively, Ardelyx has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market.

Ardelyx has a consensus price target of $13.90, suggesting a potential upside of 299.43%. Given Ardelyx's stronger consensus rating and higher possible upside, analysts plainly believe Ardelyx is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Siga Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ardelyx	2 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.75

In the previous week, Ardelyx had 21 more articles in the media than Siga Technologies. MarketBeat recorded 21 mentions for Ardelyx and 0 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 0.80 beat Ardelyx's score of -0.03 indicating that Siga Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Siga Technologies	Positive
Ardelyx	Neutral

Siga Technologies has a net margin of -5.19% compared to Ardelyx's net margin of -12.35%. Siga Technologies' return on equity of -1.55% beat Ardelyx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Siga Technologies	-5.19%	-1.55%	-1.32%
Ardelyx	-12.35%	-36.00%	-10.77%

Siga Technologies has higher earnings, but lower revenue than Ardelyx. Siga Technologies is trading at a lower price-to-earnings ratio than Ardelyx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Siga Technologies	$53.66M	4.24	$23.28M	-$0.05	N/A
Ardelyx	$407.32M	2.13	-$61.60M	-$0.22	N/A

Summary

Ardelyx beats Siga Technologies on 9 of the 17 factors compared between the two stocks.

How does Siga Technologies compare to Inventiva?

Siga Technologies (NASDAQ:SIGA) and Inventiva (NASDAQ:IVA) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings.

Inventiva has a consensus price target of $15.75, suggesting a potential upside of 356.52%. Given Inventiva's stronger consensus rating and higher possible upside, analysts plainly believe Inventiva is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Siga Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Inventiva	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	3 Strong Buy rating(s)	3.09

In the previous week, Inventiva had 3 more articles in the media than Siga Technologies. MarketBeat recorded 3 mentions for Inventiva and 0 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 0.80 beat Inventiva's score of 0.24 indicating that Siga Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Siga Technologies	Positive
Inventiva	Neutral

55.4% of Siga Technologies shares are held by institutional investors. Comparatively, 19.1% of Inventiva shares are held by institutional investors. 2.7% of Siga Technologies shares are held by insiders. Comparatively, 32.0% of Inventiva shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Siga Technologies has higher revenue and earnings than Inventiva.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Siga Technologies	$53.66M	4.24	$23.28M	-$0.05	N/A
Inventiva	$4.48M	159.85	-$400.67M	N/A	N/A

Inventiva has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Inventiva's return on equity of 0.00% beat Siga Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Siga Technologies	-5.19%	-1.55%	-1.32%
Inventiva	N/A	N/A	N/A

Siga Technologies has a beta of 0.97, suggesting that its share price is 3% less volatile than the broader market. Comparatively, Inventiva has a beta of 0.71, suggesting that its share price is 29% less volatile than the broader market.

Summary

Inventiva beats Siga Technologies on 10 of the 15 factors compared between the two stocks.

How does Siga Technologies compare to Achieve Life Sciences?

Achieve Life Sciences (NASDAQ:ACHV) and Siga Technologies (NASDAQ:SIGA) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

Siga Technologies has higher revenue and earnings than Achieve Life Sciences. Siga Technologies is trading at a lower price-to-earnings ratio than Achieve Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Achieve Life Sciences	N/A	N/A	-$54.65M	-$1.55	N/A
Siga Technologies	$53.66M	4.24	$23.28M	-$0.05	N/A

33.5% of Achieve Life Sciences shares are owned by institutional investors. Comparatively, 55.4% of Siga Technologies shares are owned by institutional investors. 1.8% of Achieve Life Sciences shares are owned by insiders. Comparatively, 2.7% of Siga Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Achieve Life Sciences presently has a consensus price target of $15.00, suggesting a potential upside of 91.57%. Given Achieve Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe Achieve Life Sciences is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Achieve Life Sciences	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	3.00
Siga Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Achieve Life Sciences has a beta of 2.25, meaning that its stock price is 125% more volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market.

In the previous week, Achieve Life Sciences had 5 more articles in the media than Siga Technologies. MarketBeat recorded 5 mentions for Achieve Life Sciences and 0 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 0.80 beat Achieve Life Sciences' score of 0.14 indicating that Siga Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Achieve Life Sciences	Neutral
Siga Technologies	Positive

Achieve Life Sciences has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Siga Technologies' return on equity of -1.55% beat Achieve Life Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Achieve Life Sciences	N/A	-511.12%	-82.35%
Siga Technologies	-5.19%	-1.55%	-1.32%

Summary

Achieve Life Sciences and Siga Technologies tied by winning 8 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to Glass House Brands?

Glass House Brands (NYSE:GLAS) and Siga Technologies (NASDAQ:SIGA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.

In the previous week, Siga Technologies' average media sentiment score of 0.80 beat Glass House Brands' score of 0.00 indicating that Siga Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Glass House Brands	Neutral
Siga Technologies	Positive

Glass House Brands presently has a consensus price target of $16.00, suggesting a potential upside of 104.66%. Given Glass House Brands' stronger consensus rating and higher probable upside, analysts clearly believe Glass House Brands is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glass House Brands	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Siga Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

55.4% of Siga Technologies shares are held by institutional investors. 2.7% of Siga Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Glass House Brands has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Glass House Brands' return on equity of 0.00% beat Siga Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Glass House Brands	N/A	N/A	N/A
Siga Technologies	-5.19%	-1.55%	-1.32%

Siga Technologies has higher revenue and earnings than Glass House Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glass House Brands	N/A	N/A	N/A	N/A	N/A
Siga Technologies	$53.66M	4.24	$23.28M	-$0.05	N/A

Summary

Glass House Brands beats Siga Technologies on 6 of the 10 factors compared between the two stocks.

How does Siga Technologies compare to Gyre Therapeutics?

Siga Technologies (NASDAQ:SIGA) and Gyre Therapeutics (NASDAQ:GYRE) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and risk.

Gyre Therapeutics has a consensus price target of $16.00, suggesting a potential upside of 116.22%. Given Gyre Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Gyre Therapeutics is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Siga Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Gyre Therapeutics	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

55.4% of Siga Technologies shares are owned by institutional investors. Comparatively, 24.0% of Gyre Therapeutics shares are owned by institutional investors. 2.7% of Siga Technologies shares are owned by company insiders. Comparatively, 9.5% of Gyre Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Siga Technologies has a net margin of -5.19% compared to Gyre Therapeutics' net margin of -15.47%. Siga Technologies' return on equity of -1.55% beat Gyre Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Siga Technologies	-5.19%	-1.55%	-1.32%
Gyre Therapeutics	-15.47%	-6.57%	-5.35%

Siga Technologies has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market. Comparatively, Gyre Therapeutics has a beta of 1.92, suggesting that its stock price is 92% more volatile than the broader market.

Siga Technologies has higher earnings, but lower revenue than Gyre Therapeutics. Siga Technologies is trading at a lower price-to-earnings ratio than Gyre Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Siga Technologies	$53.66M	4.24	$23.28M	-$0.05	N/A
Gyre Therapeutics	$116.59M	7.08	$5.03M	-$0.21	N/A

In the previous week, Gyre Therapeutics had 2 more articles in the media than Siga Technologies. MarketBeat recorded 2 mentions for Gyre Therapeutics and 0 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 0.80 beat Gyre Therapeutics' score of 0.42 indicating that Siga Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Siga Technologies	Positive
Gyre Therapeutics	Neutral

Summary

Gyre Therapeutics beats Siga Technologies on 9 of the 16 factors compared between the two stocks.

Get Siga Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SIGA vs. The Competition

Export

Metric	Siga Technologies	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$234.23M	$12.60B	$7.31B	$13.29B
Dividend Yield	N/A	2.63%	2.52%	12.57%
P/E Ratio	-63.40	792.28	274.08	25.69
Price / Sales	4.24	862.22	638.21	78.99
Price / Cash	9.79	88.64	77.80	52.76
Price / Book	1.14	10.59	10.47	6.32
Net Income	$23.28M	$2.81B	$3.49B	$359.73M
7 Day Performance	3.93%	-0.11%	-0.67%	0.17%
1 Month Performance	7.82%	-1.34%	-3.17%	-3.27%
1 Year Performance	-64.42%	2.86%	15.14%	5.58%

Siga Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SIGA Siga Technologies	0.7246 of 5 stars	$3.17 -2.8%	N/A	-65.0%	$234.23M	$53.66M	N/A	49
ARDX Ardelyx	2.6701 of 5 stars	$3.40 -3.6%	$13.90 +309.4%	-43.4%	$846M	$407.32M	N/A	489	Trending News
IVA Inventiva	2.6127 of 5 stars	$3.85 -0.9%	$15.75 +309.5%	-39.2%	$798.84M	$4.48M	N/A	73	Upcoming Earnings High Trading Volume
ACHV Achieve Life Sciences	2.7546 of 5 stars	$7.31 +1.0%	$15.00 +105.3%	+157.6%	$751.70M	N/A	N/A	28
GLAS Glass House Brands	2.7043 of 5 stars	$8.01 -1.1%	$16.00 +99.7%	N/A	$751.62M	N/A	N/A	357	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SIGA) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Siga Technologies (SIGA) Competitors

SIGA vs. ARDX, IVA, ACHV, GLAS, and GYRE

How does Siga Technologies compare to Ardelyx?

Summary

How does Siga Technologies compare to Inventiva?

Summary

How does Siga Technologies compare to Achieve Life Sciences?

Summary

How does Siga Technologies compare to Glass House Brands?

Summary

How does Siga Technologies compare to Gyre Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SIGA vs. The Competition

Siga Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Siga Technologies (SIGA) Competitors

SIGA vs. ARDX, IVA, ACHV, GLAS, and GYRE

How does Siga Technologies compare to Ardelyx?

Do insiders and institutionals believe in SIGA or ARDX?

Which has more volatility and risk, SIGA or ARDX?

Do analysts prefer SIGA or ARDX?

Does the media refer more to SIGA or ARDX?

Is SIGA or ARDX more profitable?

Which has stronger valuation and earnings, SIGA or ARDX?

Summary

How does Siga Technologies compare to Inventiva?

Do analysts rate SIGA or IVA?

Does the media refer more to SIGA or IVA?

Do insiders and institutionals believe in SIGA or IVA?

Which has preferable valuation & earnings, SIGA or IVA?

Is SIGA or IVA more profitable?

Which has more volatility & risk, SIGA or IVA?

Summary

How does Siga Technologies compare to Achieve Life Sciences?

Which has stronger valuation & earnings, ACHV or SIGA?

Do insiders & institutionals have more ownership in ACHV or SIGA?

Do analysts rate ACHV or SIGA?

Which has more risk & volatility, ACHV or SIGA?

Does the media prefer ACHV or SIGA?

Is ACHV or SIGA more profitable?

Summary

How does Siga Technologies compare to Glass House Brands?

Does the media prefer GLAS or SIGA?

Do analysts prefer GLAS or SIGA?

Do insiders and institutionals hold more shares of GLAS or SIGA?

Is GLAS or SIGA more profitable?

Which has better earnings and valuation, GLAS or SIGA?

Summary

How does Siga Technologies compare to Gyre Therapeutics?

Do analysts prefer SIGA or GYRE?

Do insiders and institutionals hold more shares of SIGA or GYRE?

Is SIGA or GYRE more profitable?

Which has more volatility and risk, SIGA or GYRE?

Which has higher valuation and earnings, SIGA or GYRE?

Does the media favor SIGA or GYRE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SIGA vs. The Competition

Siga Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools